IBDEI11K ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18663,1,3,0)
 ;;=3^11730
 ;;^UTILITY(U,$J,358.3,18664,0)
 ;;=11732^^122^1191^6^^^^1
 ;;^UTILITY(U,$J,358.3,18664,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18664,1,2,0)
 ;;=2^Avulsion of Nail Plate,part/comp,ea addl nail
 ;;^UTILITY(U,$J,358.3,18664,1,3,0)
 ;;=3^11732
 ;;^UTILITY(U,$J,358.3,18665,0)
 ;;=11740^^122^1191^7^^^^1
 ;;^UTILITY(U,$J,358.3,18665,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18665,1,2,0)
 ;;=2^Evacuation Subungual Hematoma
 ;;^UTILITY(U,$J,358.3,18665,1,3,0)
 ;;=3^11740
 ;;^UTILITY(U,$J,358.3,18666,0)
 ;;=11750^^122^1191^8^^^^1
 ;;^UTILITY(U,$J,358.3,18666,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18666,1,2,0)
 ;;=2^Excision of Nail and Nail Matrx, partial or complete, for permanent removal
 ;;^UTILITY(U,$J,358.3,18666,1,3,0)
 ;;=3^11750
 ;;^UTILITY(U,$J,358.3,18667,0)
 ;;=11755^^122^1191^9^^^^1
 ;;^UTILITY(U,$J,358.3,18667,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18667,1,2,0)
 ;;=2^Biopsy of Nail Unit
 ;;^UTILITY(U,$J,358.3,18667,1,3,0)
 ;;=3^11755
 ;;^UTILITY(U,$J,358.3,18668,0)
 ;;=11760^^122^1191^10^^^^1
 ;;^UTILITY(U,$J,358.3,18668,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18668,1,2,0)
 ;;=2^Repair of Nail Bed
 ;;^UTILITY(U,$J,358.3,18668,1,3,0)
 ;;=3^11760
 ;;^UTILITY(U,$J,358.3,18669,0)
 ;;=11765^^122^1191^11^^^^1
 ;;^UTILITY(U,$J,358.3,18669,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18669,1,2,0)
 ;;=2^Wedge Excision of Skin Nail Fold
 ;;^UTILITY(U,$J,358.3,18669,1,3,0)
 ;;=3^11765
 ;;^UTILITY(U,$J,358.3,18670,0)
 ;;=11055^^122^1192^1^^^^1
 ;;^UTILITY(U,$J,358.3,18670,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18670,1,2,0)
 ;;=2^Trim Skin Lesion, Single Lesion
 ;;^UTILITY(U,$J,358.3,18670,1,3,0)
 ;;=3^11055
 ;;^UTILITY(U,$J,358.3,18671,0)
 ;;=11056^^122^1192^2^^^^1
 ;;^UTILITY(U,$J,358.3,18671,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18671,1,2,0)
 ;;=2^Trim Skin Lesion,2-4 Lesions
 ;;^UTILITY(U,$J,358.3,18671,1,3,0)
 ;;=3^11056
 ;;^UTILITY(U,$J,358.3,18672,0)
 ;;=11057^^122^1192^3^^^^1
 ;;^UTILITY(U,$J,358.3,18672,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18672,1,2,0)
 ;;=2^Trim Skin Lesions, Over 4
 ;;^UTILITY(U,$J,358.3,18672,1,3,0)
 ;;=3^11057
 ;;^UTILITY(U,$J,358.3,18673,0)
 ;;=17000^^122^1193^1^^^^1
 ;;^UTILITY(U,$J,358.3,18673,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18673,1,2,0)
 ;;=2^Destruction, all benign or premalignant lesions other than skin tags or cutaneous vascular proliferative lesion; 1st lesion
 ;;^UTILITY(U,$J,358.3,18673,1,3,0)
 ;;=3^17000
 ;;^UTILITY(U,$J,358.3,18674,0)
 ;;=17003^^122^1193^2^^^^1
 ;;^UTILITY(U,$J,358.3,18674,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18674,1,2,0)
 ;;=2^Destruction, all benign or premalignant lesions other than skin tags or cutaneous vascular proliferative lesions; 2nd-14th lesion, each
 ;;^UTILITY(U,$J,358.3,18674,1,3,0)
 ;;=3^17003
 ;;^UTILITY(U,$J,358.3,18675,0)
 ;;=17004^^122^1193^3^^^^1
 ;;^UTILITY(U,$J,358.3,18675,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18675,1,2,0)
 ;;=2^Destruction, all benign or premalignant lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions
 ;;^UTILITY(U,$J,358.3,18675,1,3,0)
 ;;=3^17004
 ;;^UTILITY(U,$J,358.3,18676,0)
 ;;=17110^^122^1193^4^^^^1
 ;;^UTILITY(U,$J,358.3,18676,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18676,1,2,0)
 ;;=2^Destruction, of flat warts, molluscum contagiosum, or milia; up to 14 lesions
 ;;^UTILITY(U,$J,358.3,18676,1,3,0)
 ;;=3^17110
 ;;^UTILITY(U,$J,358.3,18677,0)
 ;;=17111^^122^1193^5^^^^1
 ;;^UTILITY(U,$J,358.3,18677,1,0)
 ;;=^358.31IA^3^2
